Stelkast Surpass Acetabular System
Prosthesis, hip, semi-constrained, metal/ceramic/ceramic/metal, cemented or uncemented. PMA P040051, from Stelkast Company (Mcmurray, PA). Product code MRA, class 3.
As of Nov 19, 2026, P040051 is an FDA PMA held by Stelkast Company, approved on May 12, 2006 after 501 days, with no recalls tied to it in FDA's recall database.
- Review time: 501 days
- Supplements: 2
- Recalls: 0
- Cited as a predicate by: 1 device
Approval for the Stelkast Surpass Acetabular System. The device is indicated for cementless use in primary total hip arthroplasty in skeletally mature individuals with non-inflammatory degenerative joint disease such as osteoarthritis, avascular necrosis, congenital hip dysplasia, and traumatic arthritis.
- Design
- Prospective, multi-center, non-masked historical control clinical trial (TRANSCEND ceramic hip system, P010001)
- Enrolled
- 965
- Where
- 12 sites
- Primary endpoint
- Implant survivorship at 2 years (primary efficacy); complication rates (primary safety)
- Result
- Cumulative Kaplan-Meier survivorship 0.9876 (SE 0.0066) at 24 months; no pre-specified success/failure criteria
- Exp Acetabular Liner, Models SC3342 Non-Hooded 28MM, SC3343 Hooded 28MMK094035 · Stelkast Company · Mar 24, 2011
| Apr 22, 2011 | S002Postapproval Study Protocol - OSB | Normal 180 Day Track No User Fee |
| May 8, 2009 | S001Process Change - Manufacturer/Sterilizer/Packager/Supplier | 135 Review Track For 30-Day Notice |
- Document
- Approval order (PDF) ↗
- Type
- Original PMA
- Received
- Dec 27, 2004
- Review panel
- Orthopedic
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files